Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
61
ONPH Quote, Financials, Valuation and Earnings
Last price:
$0.1000
Seasonality move
:
2771.78%
Day range:
$0.0600 - $0.1500
52-week range:
$0.0000 - $0.3640
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.81x
Volume:
34.2K
Avg. volume:
80.7K
1-year change:
99900%
Market cap:
$115.4K
Revenue:
--
EPS (TTM):
-$0.16
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Oncology Pharma, Inc. has -- downside to fair value with a price target of -- per share.
ONPH vs. S&P 500
-
Over the past 5 trading days, Oncology Pharma, Inc. has underperformed the S&P 500 by -3.25% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Oncology Pharma, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Oncology Pharma, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Oncology Pharma, Inc. reported revenues of --.
Earnings Growth
-
Oncology Pharma, Inc. has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Oncology Pharma, Inc. reported earnings per share of --.
Enterprise value:
74.4K
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
6.41x
Price / Operating cash flow:
31.51x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-326.11%
Net Income Margin (TTM):
--
Return On Equity:
-591.02%
Return On Invested Capital:
-366.45%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -$100.9K | -- | -$800 | |
| EBITDA | -- | -- | -$100.9K | -- | -$800 | |
| Diluted EPS | -- | -- | -$0.16 | -- | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29K | $400 | -- | -- | $42K | |
| Total Assets | $2.1M | $2.1M | -- | -- | $42K | |
| Current Liabilities | $850.6K | $1M | -- | -- | $800 | |
| Total Liabilities | $850.6K | $1M | -- | -- | $800 | |
| Total Equity | $1.3M | $1.1M | -- | -- | $41.2K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2021-12-31 | 2022-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$53K | $305.9K | $11.6K | $21.3K | -$2K | |
| Cash From Investing | -$59.7K | -$2M | -$45K | -$200K | -- | |
| Cash From Financing | $113.6K | $1.7M | $4.8K | $2.2K | $600 | |
| Free Cash Flow | -$53K | $305.9K | $11.6K | $21.3K | -$2K | |
ONPH
Sector
Market Cap
$115.4K
$23.9M
Price % of 52-Week High
27.47%
47.44%
Dividend Yield
0%
0%
Shareholder Yield
2797.01%
-1.9%
1-Year Price Total Return
99900%
-18.29%
Beta (5-Year)
0.917
0.513
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.0883
200-day SMA
Buy
Level
$0.0076
Bollinger Bands (100)
Buy
Level
-0.0152 - 0.0448
Chaikin Money Flow
Sell
Level
-721.1K
20-day SMA
Buy
Level
$0.0567
Relative Strength Index (RSI14)
Buy
Level
60.9027
ADX Line
Buy
Level
50.6601
Williams %R
Neutral
Level
-74.9149
50-day SMA
Buy
Level
$0.0260
MACD (12, 26)
Buy
Level
0.0241
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Sell
Level
-79.2K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.8471)
Buy
CA Score
(Annual)
Level (-0.0532)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (9411.5765)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Oncology Pharma, Inc. engages in the development, manufacture and commercialization of therapeutics. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
Stock Forecast FAQ
In the current month, ONPH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ONPH average analyst price target in the past 3 months is --.
-
Where Will Oncology Pharma, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Oncology Pharma, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Oncology Pharma, Inc.?
Analysts are divided on their view about Oncology Pharma, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Oncology Pharma, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Oncology Pharma, Inc.'s Price Target?
The price target for Oncology Pharma, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ONPH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Oncology Pharma, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ONPH?
You can purchase shares of Oncology Pharma, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oncology Pharma, Inc. shares.
-
What Is The Oncology Pharma, Inc. Share Price Today?
Oncology Pharma, Inc. was last trading at $0.1000 per share. This represents the most recent stock quote for Oncology Pharma, Inc.. Yesterday, Oncology Pharma, Inc. closed at $0.1000 per share.
-
How To Buy Oncology Pharma, Inc. Stock Online?
In order to purchase Oncology Pharma, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ONPH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ONPH
Sector
P/E ratio
--
21.37x
PEG ratio
--
-0.01x
P/B ratio
2.81x
1.72x
Price / LTM sales
--
1.44x
Growth Metrics
ONPH
Sector
Revenue growth
--
3.44%
Earnings growth
100%
14.97%
Revenue (5-year growth)
-100%
6.27%
Earnings forecast
--
-$0.22
Profitability
ONPH
Sector
Profitability FY 2025
--
$2.4M
Return on invested capital
-366.45%
-33.43%
Return on assets
-326.11%
-29.45%
Return on equity
-591.02%
-40.29%
Earnings Date
Last Earnings Date
Apr
5
Next Earnings Date
Apr
5
Estimated Next Earnings Date
Jul
5
Balance Sheet
ONPH
Sector
Total cash
$42K
$25.6M
Short term investments
--
$22.7M
Total assets
$42K
$70.4M
Long term debt
--
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 4
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 4
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
